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Abstract : Chlorella extract （CE） has been shown to induce production of T 
helper-1 cytokines, and regulate serum IgE levels in animal models of asthma.  We 
aimed to evaluate whether CE could inhibit ovalbumin （OVA）-induced airway 
hyperresponsiveness （AHR） and airway remodeling in a murine model of asthma.  
Balb/c mice were allocated to four groups : a control group （no OVA exposure, 
not given CE）, a CE group （no OVA exposure, given CE）, an asthma group （sen-
sitized/challenged with OVA, not given CE） and a CE＋asthma group （sensitized/
challenged with OVA, given CE）.  In the asthma and CE＋asthma groups, mice 
were sensitized with OVA on day 0 and day 12, and then challenged with OVA 
on three consecutive days.  In the CE and CE＋asthma groups, the mice were 
given feed containing 2％ CE.  We assessed AHR to methacholine, and analyzed 
bronchoalveolar lavage uid （BALF）, serum, lung tissue and spleen cells.  Admin-
istration of CE was associated with signicantly lower AHR in OVA-sensitized and 
challenged mice.  CE administration was also associated with marked reduction of 
total cells, eosinophils and T helper-2 cytokines （IL-4, IL-5 and IL-13） in BALF.  
In addition, administration of CE signicantly decreased the numbers of periodic 
acid-Schiff （PAS）-positive cells in OVA-sensitized and challenged mice.  Administra-
tion of CE also directly suppressed IL-4, IL-5 and IL-13 production in spleen cells 
of OVA-sensitized and challenged mice.  These results indicate that CE can partly 
prevent AHR and airway remodeling in a murine model of asthma.
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Introduction
　Probiotics are defined as live microorganisms that have beneficial effects on the host by 
improving the balance of intestinal flora 1）.  Recently, many studies have revealed relationships 
between allergic diseases （such as bronchial asthma, allergic rhinitis, pollinosis and atopic 
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dermatitis） and probiotics 2，3）.  Since Chlorella contains materials that promote the growth of 
probiotics such as lactobacillus, it is considered a prebiotic.  
　Chlorella is a genus of single-celled green algae, belonging to the phylum Chlorophyta.  It 
is spherical in shape, about 2-10 µm in diameter, and does not have flagella 4）.  Chlorella cells 
contain the green photosynthetic pigment chlorophyll （in their chloroplasts）, essential amino 
acids, carbohydrates, proteins, nucleic acids, minerals, vitamins, dietary fiber, growth factors, and a 
wide range of antioxidants.  Chlorella extract （CE） is a popular dietary supplement worldwide, 
especially in Asia 5）.  
　Previous studies have shown that CE exerts benefits such as enhancing immune function, 
relieving hypertension, regulating lipid metabolism and tumors, providing antibacterial effects, 
promoting dioxin excretion, and improving body functions in people with certain illnesses, 
including two chronic illnesses-fibromyalgia and ulcerative colitis 6，7）.
　Allergy is defined as a multicellular immune disorder that is characterized by the production 
of allergen-specific IgE with a predominant T helper-2 （Th2） response 8）.  IgE production is 
promoted by IL-4 from Th2 cells and is suppressed by INF-γ stimulation.  Characteristic 
features of asthma include episodic airflow obstruction, airway inflammation, and airway 
hyperresponsiveness （AHR, the capacity of the airways to undergo exaggerated narrowing in 
response to stimuli that do not result in comparable degrees of airway narrowing in healthy 
subjects）.  Airway remodeling is associated with severe asthma due to irreversible airway 
obstruction despite high-intensity treatment.
　Lymphocytes, mast cells and eosinophils play important roles in airway inflammation, and 
studies using targeted deletion approaches have demonstrated that eosinophils are necessary 
for ovalbumin （OVA）-induced AHR and airway remodeling in mice 9，10）.  Airway eosinophilic 
inflammation is highly regulated by Th2 cytokines IL-4, IL-5 and IL-13, produced by T 
lymphocytes.  Eosinophils can also produce cytokines, chemokines, lipid mediators and growth 
factors that induce lung fibrosis.  Airway remodeling that includes non-reversible structural 
changes, such as increases in smooth muscle mass, mucus hyperplasia and subepithelial fibrosis, 
might explain the progressive loss of lung function in patients with asthma 11，12）.  Allergic airway 
inflammation is caused by Th2 cells, mast cells and eosinophils.  The Th2 response may be 
suppressed by activating T helper-1 （Th1） response, to improve the balance between Th1 and 
Th2 responses.
　It has been reported that CE strongly activates Th1 cells and increases the production of INF-γ 
and IL-2, to strengthen the immune system and host defense 13）.  CE has also been shown to 
enhance intestinal barrier function and suppress IL-5 production in mast cells 14）.  Furthermore, 
CE regulates serum IgE levels and eosinophils in airway epithelium in animal models of 
asthma 15，16）.
　In this study, we examined the effect of CE on a murine model of asthma, with a focus 
on AHR and airway remodeling.  This included investigation of whether CE suppresses IgE 
production.
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Materials and methods
Animals
　BALB/c mice （female, 6-8 weeks old, weight range 19-24 g） were obtained from the Saitama 
Experimental Animals Supply Co., Ltd. （Saitama, Japan）.  All animal experiments were 
performed under Animal Care and Use Committee approval and conformed to institutional 
guidelines （Permit Number : 04097）.  
　Mice were allocated to four groups.  Mice in the control group were not sensitized or 
challenged with OVA （they were exposed to saline instead） and were not given CE in their 
feed.  Mice in the CE group were not sensitized or challenged with OVA （they were exposed 
to saline instead） and were given CE in their feed.  Mice in the asthma group were sensitized 
and challenged with OVA and were not given CE in their feed.  Mice in the CE＋asthma 
group were sensitized and challenged with OVA and were given CE in their feed.
CE treatment and OVA-sensitization protocol
　BALB/c mice were sensitized with 50 µg/mouse of OVA （Sigma-Aldrich, St Louis, MO, USA） 
by intra-peritoneal injection on day 0 and day 12, and later challenged intra-nasally with 20 µg/
mouse of OVA on three consecutive days （days 25-27） to develop a murine model of asthma. 
Mice were sacrificed 24 hours after the final OVA challenge.  During the 2 weeks before and 
4 weeks after the first sensitization with OVA, the mice were given feed containing 2％ CE, 
as described in Fig. 1.  The dry feed containing 2％ CE was kindly provided by the research 
laboratories of Chlorella Industry Co. （Fukuoka, Japan）.  
Measurement of AHR to methacholine
　Changes in lung resistance induced by methacholine （MCh） were measured with the Buxco 
invasive measurement system （Buxco Electronics Inc., Troy, NY, USA） 24 hours after the 
last OVA challenge.  Mice were anesthetized with 80 mg/kg body weight of intra-peritoneal 
pentobarbital.  Tracheas were connected to a ventilator via a 19-gauge needle.  The mice were 
ventilated at a frequency of 150 breaths per minute with 200-µl stroke volumes.  Aerosolized 
saline and increasing concentrations of MCh （dissolved in saline at 6.25 mg/ml, 12.5 mg/ml and 
25 mg/ml） were administered.  Airflow and pressure changes were recorded with Bio System XA 
software （Buxco Electronics Inc.）.
Bronchoalveolar lavage and cellular analysis
　Mice were sacrificed 24 hours after the last OVA challenge.  The trachea was exteriorized 
by blunt dissection, and a small-caliber needle was inserted and secured in the airway.  Three 
successive washes of 0.30 ml saline were instilled and gently aspirated.  The recovered 
bronchoalveolar lavage fluid （BALF） was kept on ice until centrifugation.  Each sample of 
BALF was centrifuged at 300×g for 7 minutes at 4°C.  Cells were washed and resuspended 
in 100 µl of saline.  Total numbers of cells were calculated using a hemocytometer with Turk’s 
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solution （Wako, Osaka, Japan）.  Differential cell counts were performed using cytospin cell 
preparations （Cytopsin 3 ; Shandon, Pittsburgh, PA, USA） and stained with Diff-Quick （Dade 
Behring Inc., Newark, DE, USA）.  A differential count of 400 cells was performed using 
standard morphological criteria.
Measurement of cytokine levels in BALF, lung tissue and serum
　Levels of cytokines including IL-4, IL-5, IL-13, TARC （a Th2 chemokine） and IFN-γ in 
BALF and lung tissue, and OVA-specific IgE levels in serum, were measured using ELISA kits 
（R&D Systems, Minneapolis, MN, USA）, by following the manufacturer’s instructions.  Lung 
tissue was homogenized in TRIzol reagent （Invitrogen, Carlsbad, CA, USA） and extracted 
with chloroform.  RNA was precipitated with isopropanol, washed with 75％ cold ethanol, and 
resuspended in RNase-free water.  Total RNA extracted from whole lung tissue was treated with 
DNase I （Promega, Madison, WI, USA）.  Reverse transcription for cDNA synthesis using oligo 
dT primers was performed with 1 µg of total RNA using a SuperScript Ⅱ first-strand synthesis 
system （Invitrogen）.  Amplification of each cDNA was performed with aTaqDNA polymerase 
（Promega）.  cDNA was measured by real-time PCR using SYBR Green/ROX master mix 
（Qiagen, Hilden, Germany） and a C1000 touch thermal cycler （BIORAD, Hercules, CA, USA）. 
The ratio of each mRNA relative to glyceraldehyde 3-phosphate dehydrogenase （GAPDH） 
mRNA was calculated with the ΔΔCt threshold cycle method.  Mouse primers for IL-4, IL-5 and 
IL-13 were obtained from Qiagen.
Histopathological analysis of lung tissue
　After performing bronchoalveolar lavage, lungs were dissected from the chest and inflated with 
Fig. 1.  Chlorella extract （CE） treatment and OVA-sensitization protocol
Mice were sensitized with intra-peritoneal （i.p.） injection of OVA （50 µg/mouse） and 
then challenged intra-nasally （i.n.） with OVA （20 µg/mouse） to develop a murine 
model of asthma.  Mice were administered feed containing 2％ CE, beginning 2 
weeks before the first sensitization.
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500 µl of 10％ formalin in phosphate-buffered saline （PBS） （pH 7.4） for 24 hours, inflated at 
10 cm H2O pressure.  Lung tissue samples were dehydrated in ethanol, embedded in paraffin, 
sectioned （at 5 µm）, and stained using the periodic acid-Schiff （PAS） staining system （Sigma-
Aldrich, St. Louis, MO, USA）.  An optical microscope with ×100 and ×400 magnification 
was used to analyze the lung tissue samples.  For analysis of goblet cell hyperplasia, four 
lung sections were examined per mouse, and percentages of PAS-positive epithelial cells were 
calculated for four airways from one section.  Masson trichrome staining was used to determine 
collagen deposition in four airways from four different sections per mouse by classification on a 
0-4 scale.  Semiquantitative analyses were performed by two independent observers who were 
blinded to information about the four groups.  
Cytokine production by spleen cells
　Spleen cells isolated from mice in the control, asthma and CE＋asthma groups were 
suspended in RPMI 1640 medium with 10％ fetal bovine serum and antibiotics （penicillin, 100 
mg/ml ; streptomycin, 100 U/ml） at a concentration of 4.0×10 6 cells/ml.  Cells were aliquoted 
into 48-well plates and stimulated with OVA （100 µg/ml） at 37°C in 5％ CO2.  For analysis 
of cytokine production, cell culture supernatants were collected 72 hours after stimulation with 
OVA.  
Statistical analysis
　For comparisons between two groups, we used the unpaired Student’s t test.  For comparisons 
of three or more groups, we used one-way ANOVA with Sidak’s correction for multiple 
comparisons.  Prism software （GraphPad, La Jolla, CA, USA） was used to perform these 
analyses.  Data are expressed as mean±SEM, and P＜ 0.05 was considered statistically significant. 
Results
Treatment with CE decreased AHR
　When we assessed AHR to MCh, there was no difference in airway resistance between mice 
in the CE group and mice in the control group.  AHR to MCh was accelerated in mice in the 
asthma group compared to mice in the control group.  AHR to MCh was significantly inhibited 
in mice in the CE＋asthma group compared to mice in the asthma group （Fig. 2）.
Treatment with CE reduced airway inammation
　CE administration did not change the total numbers of cells （Fig. 3a） or the numbers of 
macrophages, eosinophils and lymphocytes （Fig. 3b） in BALF （control group vs CE group）. 
However, the total numbers of cells （Fig. 3a） and the numbers of eosinophils and lymphocytes 
（Fig. 3b） in BALF in the CE＋asthma group mice were significantly decreased when compared 
with mice in the asthma group.
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Treatment with CE reduced cytokine levels in BALF and lung tissue
　IL-4 and TARC levels were significantly decreased in BALF of CE＋asthma group mice 
when compared with asthma group mice （Fig. 3c）.  However, there were no differences in 
INF-γ levels in BALF between the groups （Fig. 3c）.  Although IL-5 and IL-13 could not be 
detected in BALF by ELISA （data not shown）, the mRNA levels of IL-4, IL-5 and IL-13 in 
lung tissue were decreased in mice in the CE＋asthma group when compared with mice in the 
asthma group （Fig. 3d）.
Treatment with CE reduced OVA-specic IgE levels in serum
　Serum levels of OVA-specific IgE were significantly increased in mice in the asthma group 
when compared with mice in the control and CE groups, and this increase was significantly 
smaller in the CE＋asthma group （Fig. 4）.
Treatment with CE reduced airway remodeling and airway brosis
　Mice in the asthma group had an increase in the percentage of PAS-positive airway epithelial 
cells compared with those in the control group （Fig. 5a）.  Treatment with CE significantly reduced 
the percentage of PAS-positive airway epithelial cells induced by OVA challenge （Fig. 5a）. 
When airway fibrosis was studied by treating tissue with Masson trichrome stain, the increase in 
airway fibrosis by OVA was significantly inhibited by treatment with CE （Fig. 5b）.
Fig. 2.   Treatment with Chlorella extract （CE） decreased airway 
hyperresponsiveness （AHR）
AHR to methacholine in the control group, CE group, asthma group 
and CE＋asthma group （n＝8 for each group, data obtained from 
two separate experiments）, expressed as percentage change from 
baseline level of lung resistance.  Results are mean values, with error 
bars representing SEM.
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Treatment with CE inhibited cytokine production by spleen cells
　In spleen cells of mice in the asthma group, CE did not increase INF-γ expression （data not 
shown）, but CE significantly inhibited OVA-stimulated production of Th2 cytokines IL-4, IL-5 
and IL-13 （Fig. 6）.  
Discussion
　We examined the effects of CE in a mouse model of OVA-induced asthma.  We demonstrated 
that CE suppressed AHR induced by MCh, and signs of airway inflammation-total numbers of 
cells, and numbers of eosinophils and lymphocytes in BALF.  In addition, CE suppressed airway 
smooth muscle hypertrophy and goblet cell hyperplasia, which are features of airway remodeling 
a
c
d
b
Fig. 3.  Treatment with CE reduced cytokine levels
Analysis of inflammatory cells and cytokines in BALF.  （a） Total numbers of inflammatory 
cells in BALF ; n.s＝not significant.  （b） Numbers of macrophages （Mac）, eosinophils （Eo） 
and lymphocytes （Lym） in BALF.  （c） Cytokine levels in BALF measured by ELISA.  （d） 
Cytokine levels in lung tissue measured by ELISA.  Results are mean values, with error 
bars representing SEM （n＝8 for each group）.
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Fig. 5.  Treatment with CE reduced airway remodeling and airway fibrosis
（a）  Percentage of goblet cell hyperplasia for the control, asthma and CE＋asthma groups （n＝8 for 
each group）, and representative lung sections showing PAS staining for the control, asthma and 
CE＋asthma groups at ×100 and ×400 magnification.  
（b）  Scoring of airway fibrosis for the control, CE, asthma and CE＋asthma groups （n＝8 for each 
group）, and representative lung sections showing Masson trichrome staining for the control, 
asthma and CE＋asthma groups at ×100 and ×400 magnification.  Graphed results are mean 
values, with error bars representing SEM.  The control group exhibited minimal epithelial PAS 
and Masson trichrome staining.  In contrast, the asthma group showed enhanced epithelial PAS 
and Masson trichrome staining, which were significantly inhibited by CE treatment.
a
b
Fig. 4.  Treatment with CE reduced OVA-specific IgE levels in serum
Analysis of serum OVA-specific IgE level in the control group, CE group, asthma group and CE＋
asthma group.  Results are mean values, with error bars representing SEM.
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in asthma.  To our knowledge, this is the first report on the inhibitory effects of CE on airway 
remodeling in a mouse model of asthma.  As Th2 cytokines can directly induce airway smooth 
muscle hypertrophy and goblet cell hyperplasia, CE is likely to inhibit airway smooth muscle 
hypertrophy and goblet cell hyperplasia at least partly by suppressing Th2 cytokines.
　Chlorella supplements, which contain a variety of substances, are sold as health supplements 
in East Asian countries, including Japan.  Reports on the health benefits of Chlorella include 
its use in a wide variety of diseases, ranging from depressive disorders to breast cancer 17，18）. 
However, the detailed mechanisms of action for Chlorella’s effects are unknown.  A previous 
report showed that oral administration of CE enhanced the resistance of mice to Listeria 
monocytogenes infection owing to enhancement of Th1 response 19）.  It has also been reported 
that CE prevents the release of allergic mediators by suppressing calcium uptake by mast cells, 
resulting in inhibition of immediate-type allergic reactions 20）.  In addition, polysaccharide-rich 
components of Chlorella pyrenoidosa have been shown to induce IL-1β and TNF-α production 
by macrophages.  These data suggest that Chlorella exerts its effects by shifting the Th1/Th2 
balance to Th1 dominance.  
　Allergic diseases, including asthma, are considered to be Th2 dominant, and inhibition of Th2 
cytokines has been shown to be effective in treating some allergic diseases in humans.  Mepolizumab, 
an anti-IL-5 monoclonal antibody, has dramatic effects on patients with severe asthma 21）. 
Dupilmab, a human anti-IL-4 receptor α monoclonal antibody, has been shown to improve 
skin condition in patients with atopic dermatitis 22）.  In our study, we showed that administration 
of CE decreased the number of eosinophils in BALF in a murine model of asthma.  This 
inhibition could have resulted from a CE-induced decrease in Th2 cytokines.  We also showed 
that administration of CE resulted in a significant decrease in serum IgE levels, which is in line 
Fig. 6.  Treatment with CE inhibited cytokine production by spleen cells. 
Analysis of IL-4, IL-5 and IL-13 in the supernatant after stimulation of 
spleen cells with OVA in the control, asthma and CE＋asthma groups 
（n＝8 for each group）.  Results are mean values, with error bars 
representing SEM.
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with previous data from mice 16）.  
　A previous report has shown that endotoxin levels in CE are below analytical detection 
limits 23）.  However, CE has been shown to produce lipopolysaccharide-like substances that 
contribute to the Th1 response 24）.  Also, CE has been shown to enhance IFN-γ production 
in Listeria monocytogenes-infected mice 19）, casein-injected mice 16） and OVA-immunized mice 20）. 
However, in a mouse model of Der f-induced atopic dermatitis, it has been shown that CE 
reduces eosinophilic inflammation, IL-4 expression and IFN-γ expression in skin 25）.  In our 
study, CE did not lead to an increase in IFN-γ in BALF, indicating that IFN-γ did not play a 
critical role in CE-induced inhibition of airway inflammation and AHR.
　To our knowledge, no previous studies have investigated the effects of CE on AHR in an 
animal model of asthma.  However, one study has looked at the effects of CE in chronic 
obstructive pulmonary disease （COPD）.  That study showed that CE did not change forced vital 
capacity （FVC）, forced expiratory volume in the first second （FEV1） or FEV1/FVC in patients 
with COPD 26）, suggesting that CE does not have direct bronchodilating effects.  A marked 
difference between COPD and asthma is the type of airway inflammation ; it is neutrophilic in 
COPD and eosinophilic in asthma.  This might explain why no bronchodilating effect of CE was 
seen in COPD, while AHR was reduced by CE in a model of asthma.
　A previous report indicated that CE induced maturation of dendritic cells （DCs）, and that 
the resulting mature DCs activated naive T cells and stimulated T cell proliferation and IFN-γ 
secretion 27）.  It has also been reported that CE is involved in activation of toll-like receptor 
2 （TLR2）28） and enhances Th1 cytokine production.  Furthermore, it has been reported that 
TLR2 induces regulatory T cells （Tregs）, which results in suppression of asthma manifestations 
in mice 29）.  Since TLR2 in macrophages and DCs produces inflammatory cytokines, mature DCs 
induced by CE may enhance Tregs via activation of TLR2 and result in a shift of Th1/Th2 
balance to Th1 dominance.  Chlorella containing lipopolysaccharide analogs have a powerful 
ability to lead Th1 response 25）.  CE therefore has the potential to enhance Th1 cytokine 
production.
　We examined the direct action of CE using spleen cells.  Although INF-γ was not increased 
by the addition of CE to spleen cells （data not shown）, CE suppressed production of Th2 
cytokines IL-4, IL-5 and IL-13.  These results suggest that Chlorella may directly act on T cells 
at a cellular level.  Although several mechanisms by which CE could change the balance of 
Th1 and Th2 response have been proposed, the details are unclear and further investigation is 
needed.
　Th2 cytokines are mainly produced by Th2 cells, but they are also produced by mast cells, 
basophils and type 2 innate lymphoid cells （ILC2s）30）.  We demonstrated that CE inhibits the 
production of Th2 cytokines by murine spleen cells.  This suggests that CE directly suppresses 
the production of Th2 cytokines by Th2 cells.  It has been reported that CE suppresses IL-5 
production by mast cells 14）.  Therefore, CE may suppress Th2 cytokine production not only by 
Th2 cells but also by mast cells.  ILC2s play an important role in allergen-independent Th2-
induced inflammation caused by production of IL-5 and IL-13.  However, the effect of CE on 
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ILC2s is still unknown.  
　In conclusion, we observed that CE treatment in an allergic mouse model suppressed allergic 
inflammation and AHR, the main reaction of bronchial asthma, by inhibiting the Th2 response. 
CE also directly suppressed Th2 response on immune cells including spleen cells.  These results 
suggest that CE may protect against the development of allergic asthma due to repeated allergen 
exposure.
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